Cineplex Reports Quarterly Revenue Decline of 85.4% Year Over Year
This morning Cineplex (TSX: CGX) released their financial results for the third quarter of 2020. As expected, they saw a massive
Read more
Author: Small Cap Steve
Havn Life to Supply Revive Therapeutics With Psychedelic Compounds
This morning Revive Therapeutics (CSE: RVV) announced they have signed a supply agreement with Havn Life Sciences Inc. (CSE : HAVN) to source
Read more
PopReach Receives Upgraded Price Target from Canaccord Amid $5M Investment from Alibaba Investment Arm
On Thursday, PopReach (TSXV: POPR) announced a $5.0 million investment from eWTP Tech Innovation Fund LP, a global investment arm
Read more
Mind Cure Announces new CTO, Geoff Belair
This morning Mind Cure Health Inc. (CSE: MCUR) announced the hiring of Geoff Belair as their new Chief Technology Officer. Belair was the senior
Read more
Freeman Gold Corp adds Paul Matysek as Advisor
This morning Freeman Gold Corp. (CSE: FMAN) announced they have appointed Paul Matysek as a Strategic Advisor. Matysek has over
Read more
Wood Mackenzie Estimates Energy Storage to Grow at 31% CAGR to 2030
Last week, Wood Mackenize issued a report forecasting the growth of global energy storage capacity. The report estimates that storage
Read more
Has QYOU Media Turned the Corner?
This week QYOU Media (TSXV: QYOU) announced a joint programming and marketing agreement with the Chingari platform in India. The Chingari app is considered
Read more
Revive Selects Clinical Sites for FDA Phase 3 Clinical Trials
This morning Revive Therapeutics Ltd (CSE: RVV, OTV: RVVTF), announced they have selected five clinical sites in Florida, Texas and
Read more
Khiron Receives National Strategic Project Status From Colombian Government
This morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National Interest Strategic Project by the Government
Read more
UPDATED: SEC Looking into Nikola Claims; Will GM Pull Out of Nikola Deal?
After the market, Bloomberg reported the SEC is assessing the merits of the accusations made by short-seller Hindenburg Research. The claims
Read more